Access

Article

Nature Medicine 12, 1167 - 1174 (2006)
Published online: 24 September 2006 | doi:10.1038/nm1483

Targeting of CD44 eradicates human acute myeloid leukemic stem cells

Liqing Jin1,3, Kristin J Hope1,3, Qiongli Zhai2, Florence Smadja-Joffe2 & John E Dick1

The long-term survival of patients with acute myeloid leukemia (AML) is dismally poor. A permanent cure of AML requires elimination of leukemic stem cells (LSCs), the only cell type capable of initiating and maintaining the leukemic clonal hierarchy. We report a therapeutic approach using an activating monoclonal antibody directed to the adhesion molecule CD44. In vivo administration of this antibody to nonobese diabetic-severe combined immune-deficient mice transplanted with human AML markedly reduced leukemic repopulation. Absence of leukemia in serially transplanted mice demonstrated that AML LSCs are directly targeted. Mechanisms underlying this eradication included interference with transport to stem cell–supportive microenvironmental niches and alteration of AML-LSC fate, identifying CD44 as a key regulator of AML LSCs. The finding that AML LSCs require interaction with a niche to maintain their stem cell properties provides a therapeutic strategy to eliminate quiescent AML LSCs and may be applicable to other types of cancer stem cells.

MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.

RESEARCH

Hyperglycemia Enhances DNA Fragmentation After Transient Cerebral Ischemia

Journal of Cerebral Blood Flow & Metabolism Original Article

Acute myeloid leukemia originates from a hierarchy of leukemic stem cell classes that differ in self-renewal capacity

Nature Immunology Article (01 Jul 2004)

Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell

Nature Medicine Article (01 Jul 1997)

See all 47 matches for Research